_id
690db2f2ccc777a4e85d0cab
Ticker
ATYR
Name
aTyr Pharma, Inc.
Exchange
NASDAQ
Address
10240 Sorrento Valley Road, San Diego, CA, United States, 92121
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://atyrpharma.com
Description
aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; and in Phase 1b/2a clinical trial to treat other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase, which is in preclinical development for the treatment fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.
Last Close
0.69
Volume
231460
Current Price
0.7109
Change
0.0023
Last Updated
2026-01-20T15:55:37.319Z
Image
data:image/webp;base64,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
Ipo Date
2015-05-07T00:00:00.000Z
Market Cap
69433328
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4.6364
Target Price
4.3571
Strong Buy
7
Buy
4
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
190000
Cost Of Revenue
22130000
Gross Profit
-21940000
Operating Expenses
4805000
Operating Income
-26745000
Interest Expense
-
Pretax Income
-25746000
Net Income
-25744000
Eps
-0.2649826216833414
Dividends Per Share
-
Shares Outstanding
97986634
Income Tax Expense
-
EBITDA
-25581000
Operating Margin
-14076.315789473685
Total Other Income Expense Net
999000
Cash
6150000
Short Term Investments
84052000
Receivables
1042000
Inventories
-
Total Current Assets
93014000
Property Plant Equipment
10777000
Total Assets
106652000
Payables
4064000
Short Term Debt
1429000
Long Term Debt
-
Total Liabilities
26608000
Equity
80235000
Bs_currency_symbol
USD
Depreciation
389000
Change In Working Capital
4086000
Cash From Operations
-20476000
Capital Expenditures
37000
Cash From Investing
-20377000
Cash From Financing
29617000
Net Change In Cash
-11236000
Cf_currency_symbol
USD
PE
-
PB
0.8608020476961425
ROE
-32.08574811491244
ROA
-24.138319018865094
FCF
-20513000
Fcf Percent
-107.96315789473684
Piotroski FScore
1
Health Score
34
Deep Value Investing Score
4.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
4
Net Net Investing Score
3.5
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
190000
Quarters > 0 > income Statement > cost Of Revenue
22130000
Quarters > 0 > income Statement > gross Profit
-21940000
Quarters > 0 > income Statement > operating Expenses
4805000
Quarters > 0 > income Statement > operating Income
-26745000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-25746000
Quarters > 0 > income Statement > net Income
-25744000
Quarters > 0 > income Statement > eps
-0.2649826216833414
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
97153541
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-25581000
Quarters > 0 > income Statement > operating Margin
-14076.315789473685
Quarters > 0 > income Statement > total Other Income Expense Net
999000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
6150000
Quarters > 0 > balance Sheet > short Term Investments
84052000
Quarters > 0 > balance Sheet > receivables
1042000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
93014000
Quarters > 0 > balance Sheet > property Plant Equipment
10777000
Quarters > 0 > balance Sheet > total Assets
106652000
Quarters > 0 > balance Sheet > payables
4064000
Quarters > 0 > balance Sheet > short Term Debt
1429000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
26608000
Quarters > 0 > balance Sheet > equity
80235000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-25746000
Quarters > 0 > cash Flow > depreciation
389000
Quarters > 0 > cash Flow > change In Working Capital
4086000
Quarters > 0 > cash Flow > cash From Operations
-20476000
Quarters > 0 > cash Flow > capital Expenditures
37000
Quarters > 0 > cash Flow > cash From Investing
-20377000
Quarters > 0 > cash Flow > cash From Financing
29617000
Quarters > 0 > cash Flow > net Change In Cash
-11236000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.2649826216833414
Quarters > 0 > ratios > PB
0.8608020476961425
Quarters > 0 > ratios > ROE
-32.08574811491244
Quarters > 0 > ratios > ROA
-24.138319018865094
Quarters > 0 > ratios > FCF
-20513000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-107.96315789473684
Quarters > 0 > health Score
34
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
387000
Quarters > 1 > income Statement > gross Profit
-387000
Quarters > 1 > income Statement > operating Expenses
20313000
Quarters > 1 > income Statement > operating Income
-20313000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-19532000
Quarters > 1 > income Statement > net Income
-19531000
Quarters > 1 > income Statement > eps
-0.21672158311615589
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
90120235
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-19926000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
781000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
17220000
Quarters > 1 > balance Sheet > short Term Investments
63126000
Quarters > 1 > balance Sheet > receivables
498000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
87492000
Quarters > 1 > balance Sheet > property Plant Equipment
11098000
Quarters > 1 > balance Sheet > total Assets
101534000
Quarters > 1 > balance Sheet > payables
3881000
Quarters > 1 > balance Sheet > short Term Debt
1331000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
26878000
Quarters > 1 > balance Sheet > equity
74845000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-19532000
Quarters > 1 > cash Flow > depreciation
387000
Quarters > 1 > cash Flow > change In Working Capital
4404000
Quarters > 1 > cash Flow > cash From Operations
-13894000
Quarters > 1 > cash Flow > capital Expenditures
9000
Quarters > 1 > cash Flow > cash From Investing
3301000
Quarters > 1 > cash Flow > cash From Financing
17897000
Quarters > 1 > cash Flow > net Change In Cash
7304000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.21672158311615589
Quarters > 1 > ratios > PB
0.8559887108223662
Quarters > 1 > ratios > ROE
-26.095263544658962
Quarters > 1 > ratios > ROA
-19.235920972285143
Quarters > 1 > ratios > FCF
-13903000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
42
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
383000
Quarters > 2 > income Statement > gross Profit
-383000
Quarters > 2 > income Statement > operating Expenses
15773000
Quarters > 2 > income Statement > operating Income
-15773000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-14881000
Quarters > 2 > income Statement > net Income
-14880000
Quarters > 2 > income Statement > eps
-0.17205270649660614
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
86485126
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-15390000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
892000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
10362000
Quarters > 2 > balance Sheet > short Term Investments
65987000
Quarters > 2 > balance Sheet > receivables
988000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
83271000
Quarters > 2 > balance Sheet > property Plant Equipment
11476000
Quarters > 2 > balance Sheet > total Assets
97245000
Quarters > 2 > balance Sheet > payables
1531000
Quarters > 2 > balance Sheet > short Term Debt
1290000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
22383000
Quarters > 2 > balance Sheet > equity
75050000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-14881000
Quarters > 2 > cash Flow > depreciation
383000
Quarters > 2 > cash Flow > change In Working Capital
-1577000
Quarters > 2 > cash Flow > cash From Operations
-15420000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-4420000
Quarters > 2 > cash Flow > cash From Financing
18628000
Quarters > 2 > cash Flow > net Change In Cash
-1212000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.17205270649660614
Quarters > 2 > ratios > PB
0.8192175359546968
Quarters > 2 > ratios > ROE
-19.82678214523651
Quarters > 2 > ratios > ROA
-15.30155792071572
Quarters > 2 > ratios > FCF
-15420000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
41
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
12228000
Quarters > 3 > income Statement > gross Profit
-12228000
Quarters > 3 > income Statement > operating Expenses
3592000
Quarters > 3 > income Statement > operating Income
-15820000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-14968000
Quarters > 3 > income Statement > net Income
-14967000
Quarters > 3 > income Statement > eps
-0.18092549647137257
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
82724659
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-15645000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
852000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
11055000
Quarters > 3 > balance Sheet > short Term Investments
61070000
Quarters > 3 > balance Sheet > receivables
1736000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
81954000
Quarters > 3 > balance Sheet > property Plant Equipment
11859000
Quarters > 3 > balance Sheet > total Assets
96830000
Quarters > 3 > balance Sheet > payables
4323000
Quarters > 3 > balance Sheet > short Term Debt
1252000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
26998000
Quarters > 3 > balance Sheet > equity
70019000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-14968000
Quarters > 3 > cash Flow > depreciation
-1000
Quarters > 3 > cash Flow > change In Working Capital
1620000
Quarters > 3 > cash Flow > cash From Operations
-13132000
Quarters > 3 > cash Flow > capital Expenditures
25000
Quarters > 3 > cash Flow > cash From Investing
-6085000
Quarters > 3 > cash Flow > cash From Financing
18839000
Quarters > 3 > cash Flow > net Change In Cash
-378000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.18092549647137257
Quarters > 3 > ratios > PB
0.8399000283223125
Quarters > 3 > ratios > ROE
-21.3756266156329
Quarters > 3 > ratios > ROA
-15.456986471134979
Quarters > 3 > ratios > FCF
-13157000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
42
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
235000
Annuals > 0 > income Statement > cost Of Revenue
1540000
Annuals > 0 > income Statement > gross Profit
235000
Annuals > 0 > income Statement > operating Expenses
68149000
Annuals > 0 > income Statement > operating Income
-67914000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-64022000
Annuals > 0 > income Statement > net Income
-64023000
Annuals > 0 > income Statement > eps
-0.862131826060329
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
74261265
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-66374000
Annuals > 0 > income Statement > operating Margin
-28899.57446808511
Annuals > 0 > income Statement > total Other Income Expense Net
3892000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
11055000
Annuals > 0 > balance Sheet > short Term Investments
61070000
Annuals > 0 > balance Sheet > receivables
1736000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
81954000
Annuals > 0 > balance Sheet > property Plant Equipment
11859000
Annuals > 0 > balance Sheet > total Assets
96830000
Annuals > 0 > balance Sheet > payables
4323000
Annuals > 0 > balance Sheet > short Term Debt
1252000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
26998000
Annuals > 0 > balance Sheet > equity
70019000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-64023000
Annuals > 0 > cash Flow > depreciation
1540000
Annuals > 0 > cash Flow > change In Working Capital
-6918000
Annuals > 0 > cash Flow > cash From Operations
-69119000
Annuals > 0 > cash Flow > capital Expenditures
65000
Annuals > 0 > cash Flow > cash From Investing
17233000
Annuals > 0 > cash Flow > cash From Financing
39864000
Annuals > 0 > cash Flow > net Change In Cash
-12022000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.862131826060329
Annuals > 0 > ratios > PB
0.753971540417601
Annuals > 0 > ratios > ROE
-91.43661006298291
Annuals > 0 > ratios > ROA
-66.11897139316328
Annuals > 0 > ratios > FCF
-69184000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-294.4
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
353000
Annuals > 1 > income Statement > cost Of Revenue
2741000
Annuals > 1 > income Statement > gross Profit
353000
Annuals > 1 > income Statement > operating Expenses
55272000
Annuals > 1 > income Statement > operating Income
-54919000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-50397000
Annuals > 1 > income Statement > net Income
-50389000
Annuals > 1 > income Statement > eps
-0.9399795039734743
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
53606488
Annuals > 1 > income Statement > income Tax Expense
-8000
Annuals > 1 > income Statement > EBITDA
-52178000
Annuals > 1 > income Statement > operating Margin
-15557.790368271955
Annuals > 1 > income Statement > total Other Income Expense Net
4522000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
22544000
Annuals > 1 > balance Sheet > short Term Investments
75622000
Annuals > 1 > balance Sheet > receivables
2436000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
102992000
Annuals > 1 > balance Sheet > property Plant Equipment
14046000
Annuals > 1 > balance Sheet > total Assets
120653000
Annuals > 1 > balance Sheet > payables
3529000
Annuals > 1 > balance Sheet > short Term Debt
1328000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
30183000
Annuals > 1 > balance Sheet > equity
90658000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-50389000
Annuals > 1 > cash Flow > depreciation
2741000
Annuals > 1 > cash Flow > change In Working Capital
15012000
Annuals > 1 > cash Flow > cash From Operations
-33221000
Annuals > 1 > cash Flow > capital Expenditures
4215000
Annuals > 1 > cash Flow > cash From Investing
-20127000
Annuals > 1 > cash Flow > cash From Financing
66230000
Annuals > 1 > cash Flow > net Change In Cash
12882000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.9399795039734743
Annuals > 1 > ratios > PB
0.4203584054269893
Annuals > 1 > ratios > ROE
-55.5814158706347
Annuals > 1 > ratios > ROA
-41.76356990708893
Annuals > 1 > ratios > FCF
-37436000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-106.05099150141643
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
10386000
Annuals > 2 > income Statement > cost Of Revenue
1695000
Annuals > 2 > income Statement > gross Profit
8691000
Annuals > 2 > income Statement > operating Expenses
55095000
Annuals > 2 > income Statement > operating Income
-46404000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-45343000
Annuals > 2 > income Statement > net Income
-45338000
Annuals > 2 > income Statement > eps
-1.595309204020652
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
28419569
Annuals > 2 > income Statement > income Tax Expense
-5000
Annuals > 2 > income Statement > EBITDA
-44709000
Annuals > 2 > income Statement > operating Margin
-446.793760831889
Annuals > 2 > income Statement > total Other Income Expense Net
1061000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
9981000
Annuals > 2 > balance Sheet > short Term Investments
56165000
Annuals > 2 > balance Sheet > receivables
11775000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
80871000
Annuals > 2 > balance Sheet > property Plant Equipment
11557000
Annuals > 2 > balance Sheet > total Assets
95786000
Annuals > 2 > balance Sheet > payables
3106000
Annuals > 2 > balance Sheet > short Term Debt
894000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
24502000
Annuals > 2 > balance Sheet > equity
71464000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-45343000
Annuals > 2 > cash Flow > depreciation
1695000
Annuals > 2 > cash Flow > change In Working Capital
-833000
Annuals > 2 > cash Flow > cash From Operations
-41886000
Annuals > 2 > cash Flow > capital Expenditures
1641000
Annuals > 2 > cash Flow > cash From Investing
47245000
Annuals > 2 > cash Flow > cash From Financing
5451000
Annuals > 2 > cash Flow > net Change In Cash
10810000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-1.595309204020652
Annuals > 2 > ratios > PB
0.2827083790733796
Annuals > 2 > ratios > ROE
-63.44173290048136
Annuals > 2 > ratios > ROA
-47.332595577641825
Annuals > 2 > ratios > FCF
-43527000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-4.190930098209128
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
1304000
Annuals > 3 > income Statement > gross Profit
-1304000
Annuals > 3 > income Statement > operating Expenses
32711000
Annuals > 3 > income Statement > operating Income
-34015000
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-33777000
Annuals > 3 > income Statement > net Income
-33768000
Annuals > 3 > income Statement > eps
-1.7697298834990718
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
19080878
Annuals > 3 > income Statement > income Tax Expense
-9000
Annuals > 3 > income Statement > EBITDA
-32473000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
238000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
2336000
Annuals > 3 > balance Sheet > short Term Investments
105575000
Annuals > 3 > balance Sheet > receivables
435000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
113569000
Annuals > 3 > balance Sheet > property Plant Equipment
1810000
Annuals > 3 > balance Sheet > total Assets
115537000
Annuals > 3 > balance Sheet > payables
1031000
Annuals > 3 > balance Sheet > short Term Debt
980000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
6411000
Annuals > 3 > balance Sheet > equity
109301000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-33768000
Annuals > 3 > cash Flow > depreciation
1304000
Annuals > 3 > cash Flow > change In Working Capital
-2588000
Annuals > 3 > cash Flow > cash From Operations
-33075000
Annuals > 3 > cash Flow > capital Expenditures
192000
Annuals > 3 > cash Flow > cash From Investing
-91566000
Annuals > 3 > cash Flow > cash From Financing
110025000
Annuals > 3 > cash Flow > net Change In Cash
-14616000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-1.7697298834990718
Annuals > 3 > ratios > PB
0.12410312961638044
Annuals > 3 > ratios > ROE
-30.894502337581542
Annuals > 3 > ratios > ROA
-29.22700087417883
Annuals > 3 > ratios > FCF
-33267000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.2649826216833414
Valuation > metrics > PB
0.8608020476961425
Valuation > final Score
70
Valuation > verdict
13.9% Undervalued
Profitability > metrics > ROE
-32.08574811491244
Profitability > metrics > ROA
-27.677553916614706
Profitability > metrics > Net Margin
-135.49473684210525
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.3316258490683617
Risk > metrics > Interest Coverage
-162.0909090909091
Risk > final Score
-588
Risk > verdict
High
Liquidity > metrics > Current Ratio
16.933187693428
Liquidity > metrics > Quick Ratio
16.933187693428
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-146
Prev Risks > 1
-64
Prev Risks > 2
-33
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:26:12.413Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-12
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.183
Earnings History > 0 > eps Difference
0.183
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-06
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.26
Earnings History > 1 > eps Estimate
-0.17
Earnings History > 1 > eps Difference
-0.09
Earnings History > 1 > surprise Percent
-52.9412
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-07
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.22
Earnings History > 2 > eps Estimate
-0.1845
Earnings History > 2 > eps Difference
-0.0355
Earnings History > 2 > surprise Percent
-19.2412
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-04-30
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.17
Earnings History > 3 > eps Estimate
-0.19
Earnings History > 3 > eps Difference
0.02
Earnings History > 3 > surprise Percent
10.5263
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-12
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.1809
Earnings History > 4 > eps Estimate
-0.226
Earnings History > 4 > eps Difference
0.0451
Earnings History > 4 > surprise Percent
19.9558
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-07
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.2277
Earnings History > 5 > eps Estimate
-0.22
Earnings History > 5 > eps Difference
-0.0077
Earnings History > 5 > surprise Percent
-3.5
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-07
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.2256
Earnings History > 6 > eps Estimate
-0.24
Earnings History > 6 > eps Difference
0.0144
Earnings History > 6 > surprise Percent
6
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-02
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.23
Earnings History > 7 > eps Estimate
-0.24
Earnings History > 7 > eps Difference
0.01
Earnings History > 7 > surprise Percent
4.1667
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-14
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.25
Earnings History > 8 > eps Estimate
-0.24
Earnings History > 8 > eps Difference
-0.01
Earnings History > 8 > surprise Percent
-4.1667
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-09
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.2
Earnings History > 9 > eps Estimate
-0.2
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
0
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-09
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.22
Earnings History > 10 > eps Estimate
-0.28
Earnings History > 10 > eps Difference
0.06
Earnings History > 10 > surprise Percent
21.4286
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-09
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.29
Earnings History > 11 > eps Estimate
-0.29
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
0
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-09
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.26
Earnings History > 12 > eps Estimate
-0.48
Earnings History > 12 > eps Difference
0.22
Earnings History > 12 > surprise Percent
45.8333
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-10
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.46
Earnings History > 13 > eps Estimate
-0.47
Earnings History > 13 > eps Difference
0.01
Earnings History > 13 > surprise Percent
2.1277
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-15
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.44
Earnings History > 14 > eps Estimate
-0.44
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
0
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-09
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.44
Earnings History > 15 > eps Estimate
-0.44
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
0
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-14
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.31
Earnings History > 16 > eps Estimate
-0.31
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
0
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-10
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.42
Earnings History > 17 > eps Estimate
-0.42
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
0
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-10
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.64
Earnings History > 18 > eps Estimate
-0.64
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
0
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-13
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.51
Earnings History > 19 > eps Estimate
-0.51
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
0
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-23
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.47
Earnings History > 20 > eps Estimate
-0.47
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
0
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-11-12
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.68
Earnings History > 21 > eps Estimate
-0.68
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
0
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-08-13
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.69
Earnings History > 22 > eps Estimate
-0.69
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
0
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-05-12
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
0.25
Earnings History > 23 > eps Estimate
0.25
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
0
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2020-03-26
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-1.54
Earnings History > 24 > eps Estimate
-1.54
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
0
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-11-14
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-1.47
Earnings History > 25 > eps Estimate
-1.47
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
0
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-08-14
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-1.8
Earnings History > 26 > eps Estimate
-1.8
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
0
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-05-13
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-2.52
Earnings History > 27 > eps Estimate
-3.16
Earnings History > 27 > eps Difference
0.64
Earnings History > 27 > surprise Percent
20.2532
Earnings History > 28 > period
2018-12-31
Earnings History > 28 > report Date
2019-03-25
Earnings History > 28 > date
2018-12-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-2.94
Earnings History > 28 > eps Estimate
-3.04
Earnings History > 28 > eps Difference
0.1
Earnings History > 28 > surprise Percent
3.2895
Earnings History > 29 > period
2018-09-30
Earnings History > 29 > report Date
2018-11-13
Earnings History > 29 > date
2018-09-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-3.36
Earnings History > 29 > eps Estimate
-4.35
Earnings History > 29 > eps Difference
0.99
Earnings History > 29 > surprise Percent
22.7586
Earnings History > 30 > period
2018-06-30
Earnings History > 30 > report Date
2018-08-14
Earnings History > 30 > date
2018-06-30
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-4.9
Earnings History > 30 > eps Estimate
-4.6
Earnings History > 30 > eps Difference
-0.3
Earnings History > 30 > surprise Percent
-6.5217
Earnings History > 31 > period
2018-03-31
Earnings History > 31 > report Date
2018-05-14
Earnings History > 31 > date
2018-03-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-5.04
Earnings History > 31 > eps Estimate
-0.35
Earnings History > 31 > eps Difference
-4.69
Earnings History > 31 > surprise Percent
-1340
Earnings History > 32 > period
2017-12-31
Earnings History > 32 > report Date
2018-03-19
Earnings History > 32 > date
2017-12-31
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-5.46
Earnings History > 32 > eps Estimate
-0.41
Earnings History > 32 > eps Difference
-5.05
Earnings History > 32 > surprise Percent
-1231.7073
Earnings History > 33 > period
2017-09-30
Earnings History > 33 > report Date
2017-11-14
Earnings History > 33 > date
2017-09-30
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-6.02
Earnings History > 33 > eps Estimate
-7
Earnings History > 33 > eps Difference
0.98
Earnings History > 33 > surprise Percent
14
Earnings History > 34 > period
2017-06-30
Earnings History > 34 > report Date
2017-08-14
Earnings History > 34 > date
2017-06-30
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-0.51
Earnings History > 34 > eps Estimate
-7.98
Earnings History > 34 > eps Difference
7.47
Earnings History > 34 > surprise Percent
93.609
Earnings History > 35 > period
2017-03-31
Earnings History > 35 > report Date
2017-05-10
Earnings History > 35 > date
2017-03-31
Earnings History > 35 > before After Market
-
Earnings History > 35 > currency
USD
Earnings History > 35 > eps Actual
-0.56
Earnings History > 35 > eps Estimate
-7.18
Earnings History > 35 > eps Difference
6.62
Earnings History > 35 > surprise Percent
92.2006
Earnings History > 36 > period
2016-12-31
Earnings History > 36 > report Date
2017-03-17
Earnings History > 36 > date
2016-12-31
Earnings History > 36 > before After Market
-
Earnings History > 36 > currency
USD
Earnings History > 36 > eps Actual
-7.4177
Earnings History > 36 > eps Estimate
-
Earnings History > 36 > eps Difference
0
Earnings History > 36 > surprise Percent
-
Earnings History > 37 > period
2016-09-30
Earnings History > 37 > report Date
2016-11-14
Earnings History > 37 > date
2016-09-30
Earnings History > 37 > before After Market
-
Earnings History > 37 > currency
USD
Earnings History > 37 > eps Actual
-8.1643
Earnings History > 37 > eps Estimate
-
Earnings History > 37 > eps Difference
0
Earnings History > 37 > surprise Percent
-
Earnings History > 38 > period
2016-06-30
Earnings History > 38 > report Date
2016-08-11
Earnings History > 38 > date
2016-06-30
Earnings History > 38 > before After Market
-
Earnings History > 38 > currency
USD
Earnings History > 38 > eps Actual
-9.0976
Earnings History > 38 > eps Estimate
-
Earnings History > 38 > eps Difference
0
Earnings History > 38 > surprise Percent
-
Earnings History > 39 > period
2016-03-31
Earnings History > 39 > report Date
2016-05-12
Earnings History > 39 > date
2016-03-31
Earnings History > 39 > before After Market
-
Earnings History > 39 > currency
USD
Earnings History > 39 > eps Actual
-9.5306
Earnings History > 39 > eps Estimate
-
Earnings History > 39 > eps Difference
0
Earnings History > 39 > surprise Percent
-
Earnings History > 40 > period
2015-09-30
Earnings History > 40 > report Date
2015-11-11
Earnings History > 40 > date
2015-09-30
Earnings History > 40 > before After Market
-
Earnings History > 40 > currency
USD
Earnings History > 40 > eps Actual
-6.726
Earnings History > 40 > eps Estimate
-
Earnings History > 40 > eps Difference
0
Earnings History > 40 > surprise Percent
-
Earnings History > 41 > period
2015-06-30
Earnings History > 41 > report Date
2015-08-13
Earnings History > 41 > date
2015-06-30
Earnings History > 41 > before After Market
-
Earnings History > 41 > currency
USD
Earnings History > 41 > eps Actual
-10.4238
Earnings History > 41 > eps Estimate
-
Earnings History > 41 > eps Difference
0
Earnings History > 41 > surprise Percent
-
Earnings History > 42 > period
2015-03-31
Earnings History > 42 > report Date
2015-06-19
Earnings History > 42 > date
2015-03-31
Earnings History > 42 > before After Market
-
Earnings History > 42 > currency
USD
Earnings History > 42 > eps Actual
-5.4378
Earnings History > 42 > eps Estimate
-
Earnings History > 42 > eps Difference
0
Earnings History > 42 > surprise Percent
-
aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; and in Phase 1b/2a clinical trial to treat other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase, which is in preclinical development for the treatment fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAug Update: Does aTyr Pharma Inc. have pricing power - Market Risk Analysis & Fast Gain Swing Alerts baoquankhu1.vn
Read more →aTyr Pharma, Inc. (NASDAQ:ATYR) Sees Significant Drop in Short Interest MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$4.3571
Analyst Picks
Strong Buy
7
Buy
4
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of aTyr Pharma, Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.183
Date
2025-09-30
EPS Actual
-0.26
EPS Estimate
-0.17
EPS Difference
-0.09
Surprise Percent
-52.9412%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.